Covid-19: Cell Therapy Can Cut Death Risk By 60%, Says Study
![The most frequently utilized cell type in clinical trials during the specified period was multipotent mesenchymal stem.](https://healthwire.co/wp-content/uploads/2023/09/covid19-1.jpg)
Cell therapy, a rapidly advancing field, has been utilized to address various conditions, including cancer, autoimmune disorders, heart diseases, and infectious diseases.
Share
Posts by tag
Input your search keywords and press Enter.